Following preincubation with IFNalpha, IL1beta and IL18, TLR3 and TLR7 mRNA expression was assessed using real-time PCR. Cytokine production after preincubation with IFNalpha and subsequent TLR stimulation was measured. RESULTS: Synovial TLR3/7 expression was co-expressed with IFNalpha, IL1beta and IL18, but not with TNFalpha, IL12 and IL17. Stimulation of TLR3/TLR7 on monocytes, MoDCs or synovial fibroblasts led to secretion of type I IFN but no biologically active IL1beta or IL18 could be detected. Type I IFNalpha increased TLR3/7 mRNA expression whereas IL1beta and IL18 did not. In spite of the fact that the mRNA level of TLR4 remained unchanged, IFNalpha enhanced the response to TLR4 agonists, a phenomenon that was clearly more marked in patients with RA. CONCLUSION: Type I interferons are highly co-expressed with TLR3/TLR7 in RA synovium. They enhance TLR3/TLR7-mediated cytokine production and also TLR4-mediated responses.
Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4 mediated synovial inflammation in rheumatoid arthritis (RA).
M.F. Roelofs T.R.D.J. Radstake, MD, PhD 1 .
Introduction
Rheumatoid arthritis (RA) is a systemic autoimmune disease, which is characterized by chronic inflammation of the synovial joints. Although the cause of RA is still unidentified, a role both for genetic and environmental factors has been advocated repeatedly throughout time. As environmental factors, the encounter of bacteria and/or viruses by the host was suggested to trigger autoimmunity. Indeed, evidence for the presence of at least some viruses including Cytomegalovirus (1, represented staining of a more that 60% of the cells.
Isolation and culturing of monocytes and monocyte-derived DC (MoDC).
PBMC were isolated from heparinized venous blood using density gradient in a concentration of 0,510 6 cells/ml and cultured for 16 hours at 37C and 5% CO 2 .
Isolation and culturing of RA synovial fibroblasts.
Immediately after surgery, the synovial tissue was minced and digested with Dispase at 37°C for 60 minutes. After washing, the cells were grown in Dulbecco's minimum essential medium (Gibco Invitrogen, Basel, Switzerland) supplemented with 10% FCS, 50 IU/ml penicillin/streptomycin, 2 mM L-glutamine, 10 mM HEPES, and 0.2%
Fungizone (all from Gibco Invitrogen). Cell cultures were maintained at 37°C in a humidified incubator in an atmosphere of 5% CO 2 . For the experiments, cultured synovial fibroblasts, between passages 4 and 8, were grown in 12-well culture plates (6 × 10 4 RASF/well) and cultured at for 16 hours 37C and 5% CO 2 .
Stimulation of monocytes, MoDC and RA synovial fibroblasts.
To study TLR mRNA expression upon cytokine stimulation, monocytes (which express TLR7), monocyte-derived DC and RASF (which both express TLR3) were, was added to the cells and stored at -20C until RNA isolation was performed.
To study functional up regulation of TLR, monocytes, monocyte-derived DC and RASF were, after an 16 hours resting period, stimulated IFN with (R&D systems, Minneapolis, MN, USA) for 24 hours and subsequently stimulated with the TLR3 and TLR7 agonists poly(I:C) and loxoribin respectively (both Invivogen, San Diego, USA) or medium. After another 24 hours, culture supernatants were collected and stored at -20C until cytokine measurement was performed. In addition, to investigate the role of type I IFN various cell types were pre-incubated with 100 U/ml IFN for 16 hrs.
RNA isolation and real-time PCR.
Total RNA was extracted in 1ml of TRIzol reagent (Sigma St. Louis, MO, USA), an improved single-step RNA isolation method based on the method described by Chomczynski et al. (19) . Quantitative real-time PCR was performed using the ABI/Prism 7000 sequence detection system (Applied Biosystems, Foster City, CA). PCR conditions were as followed: 2 min at 50°C and 10 min at 95°C followed by 40 cycles of 15 s at 95°C and 1 min at 60°C, with data collection in the last 30 seconds.
All PCR were performed with SYBR Green Master mix (Applied Biosystems), 10 ng cDNA, and primer concentration of 300 nmol/L in a total volume of 25 µl.
Quantification of the PCR signals was performed by comparing the cycle threshold value (C t ) of the gene of interest of each sample with the C t values of the reference gene GAPDH. Primers sequences for gene expression analysis for hGAPDH, hTLR3, hTLR7 and IL-1 are depicted in Table I .
Measurement of cytokines in culture supernatant
TNF, IL-1, IL-6 and IL-10, IL-12p70 levels were measured in the supernatant of the cell cultures, using commercially available kits (Bio-Rad Laboratories, Hercules, USA) according to the manufacturer's instructions (20) . Cytokine levels were measured and analyzed with the Bio-Plex system (Bio-Rad Laboratories). Data analysis was done with Bio-Plex Manager software (Bio-Rad Laboratories).
Statistical analysis
Correlations of the expression of TLR and cytokines in human synovial biopsies were calculated using the Pearson Correlation test. Differences in mRNA expression and cytokine production, upon cell stimulation with cytokines and TLR agonists, were calculated using Mann-Whitney U test. P values were two sided and the level of significance was set at P<0,05. 
Results

In
TLR3/7 mediated stimulation of monocytes, dendritic cells or synovial fibroblasts could not explain its co-expression with IL-1/IL-18.
Since we found co-expression between TLR3/7 and IFN, IL-1 and IL-18, we further investigated the functional relation between these mediators and TLR3/7. It is generally accepted that stimulation of TLR3/7 leads to the production of type I IFN. In line with this, we found that TLR3/7 stimulation resulted in clearly enhanced IFN mRNA and IFN protein levels (data not shown). In order to investigate the potential relation between TLR3/7 and IL-1 we stimulated TLR3-expressing monocytederived DC and synovial fibroblasts with poly(IC) and TLR7-expressing monocytes with loxoribine. All cell types investigated showed markedly increased expression of IL-1 mRNA upon stimulation of either TLR3 or TLR7, however IL-1 protein could not be detected (data not shown). The stimulation of monocytes, monocyte-derived DC or synovial fibroblasts with TLR3/7 did not lead to the secretion of IL-18 proteins.
TLR3/7 expression is regulated by IL-1, IL-18 and type I IFN.
Since TLR3/7 stimulation leads to the production of IFN, but not to IL-1/IL-18, we next investigated whether the co-expression between TLR3/7 and IL-1/IL-18 could be explained by IL-1/IL18-induced up regulation of these receptors. To this aim, we cultured monocytes (TLR7-expressing cells), monocyte-derived dendritic cells (TLR3-expressing cells) and RA synovial fibroblasts (TLR3-expressing cells) in the presence of IFN, IL-1 and IL-18. IFN did significantly enhance the TLR3 mRNA expression on RA synovial fibroblasts and monocyte-derived DC, and TLR7 mRNA expression on monocytes (Figure 1 ). This increase in TLR expression was equal between RA patients (n=5) and healthy volunteers (n=5) and was specific for TLR3 and TLR7, since the expression of TLR2 as well as TLR4 was not altered (data not shown). In contrast, IL-1 and IL-18 had no effect on the expression of TLR3/7 excluding a direct role in their co-expression with TLR3/7.
IFN mediated up regulation of TLR3/7 is functional.
As we demonstrated that expression of TLR3 and TLR7 was strongly up regulated by IFN, we sought evidence to whether this enhanced TLR expression was functional, in terms of increased TLR-mediated cytokine production. To this aim, we incubated TLR7-expressing monocytes and TLR3-expressing monocyte-derived DC and RA synovial fibroblasts (n=8) with IFN or medium and subsequently stimulated TLR3 or TLR7 with poly(IC) and loxoribine as appropriate. As anticipated, TLR7 stimulation on monocytes and TLR3 stimulation on monocyte-derived DC and RASF led to production of IL-6 and TNF, which was significantly enhanced when the cells were pre-incubated with IFN, compared to cells that were stimulated with TLR3/7 ligands alone ( Figure 2 ). These data underline that the up regulation of TLR3/7 by type I IFN is functional.
Type I IFN augments TLR4 mediated cytokine production providing the missing link explaining co-expression between TLR3/7 and IL-1/IL-18.
Since TLR4 triggering is well recognized as a potent inducer of inflammatory mediators including IL-1 and IL-18, we postulated that stimulation of TLR3/7 leading to the production of type I IFN perhaps augments the TLR4 response ending up in the production of IL-1 and IL-18. To test this, we pre-stimulated monocyte-derived DC with IFN and next stimulated them with the TLR4 agonist lipopolysaccheride (LPS). Surprisingly, pre-stimulation with IFN resulted in a marked augmentation (4-fold) of TLR4 mediated secretion of TNF by DC from healthy controls (3044 pg/ml vs. 800 pg/ml, P = 0.01, n=5) (Figure 3) . In addition, pre-incubation with type I IFN augmented the TNF production by the combination of TLR3/4 ligands by almost 3-fold (1880 pg/ml vs. 5010 pg/ml, P = < 0.01). Compared to DC from healthy controls, stimulation of DC from RA patients with TLR4 led to a clear augmented TNF production as previously described (22). Notably, DC obtained from RA patients (n=4) produced a 4-fold higher level of TNF upon stimulation with IFN/LPS (12344 pg/ml vs. 3044 pg/ml, P = 0.001) and IFN /LPS/Poly-IC (19876 pg/ml vs. 5003 pg/ml), P = 0.01) compared to those DC from healthy individuals. Altogether these data implies an augmented TLR4 response that is orchestrated by pre-stimulation with type I IFN, which is even more pronounced in RA patients.
Discussion
In this study we demonstrated that TLR3 and TLR7 in synovial tissue from RA patients was associated with the presence of IL-1, IL-18 and type I IFN. Since TLR3/7 mediated cell activation did not result in IL-1/IL-18 secretion and TLR3/7 expression was not regulated by these mediators, we sought evidence for the underlying mechanism that explains the relationship between these mediators as observed in the synovium. Remarkably, we found that pre-incubation of DC with IFN led to clear augmentation of TLR4 mediated responses. In this light it is tempting to speculate that TLR3/TLR7 triggering leads to the production of type I IFN, which in turn augments TLR4 mediated triggering leading to the production of proinflammatory mediators explaining the co-expression between TLR3/7 and IL-1/IL- TNF secretion by monocyte-derived DC co-incubated with (24 hrs) agonists for TLR3 (TLR3), TLR4 (purified LPS) or the combination of both. TNF secretion was compared between DC that were pre-stimulated with 100 U/ml IFN for 10 hrs and those who were not. DC from healthy individuals (n=5) and RA patients (n=4) were compared. Graphs represent the mean  SD. * Represents a P-value lower then 0.05.
